Picture: 123RF/LEIGH ANNEF
Picture: 123RF/LEIGH ANNEF

Aspen was recently thrust into the spotlight after research showed that one of the drugs it supplies has reduced deaths in critically ill Covid-19 patients.

Business Day TV spoke to Aspen CEO Stephen Saad about whether the company has the capacity to meet the growing demand for the drug.

Or listen to the full audio:

Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.